Results 201 to 210 of about 677,025 (380)
ABSTRACT Aim The master's program in Periodontology and Implant Therapy at the University of Freiburg, Germany, is one of the first continuing professional development (CPD) programs in periodontology delivered through a blended learning format. With over 15 years of successful operation, this study aimed to identify key factors contributing to its ...
P. Ratka‐Krüger +3 more
wiley +1 more source
A large exploratory survey of electroconvulsive therapy recipients, family members and friends: what information do they recall being given? [PDF]
Read J +5 more
europepmc +1 more source
ABSTRACT Introduction Medicine is evolving rapidly, requiring continuous education for dentists, particularly in periodontology. Particularly due to the high prevalence of periodontal diseases, treatment needs remain high. While several continuing education programmes are available, outcome assessments are rarely reported.
S. A. Peikert +4 more
wiley +1 more source
Searching for the mechanism(s) of ECT's therapeutic effect.
W. McCall, C. Andrade, P. Sienaert
semanticscholar +1 more source
ABSTRACT Introduction Evidence‐based dentistry (EBD) refers to the use of the best available evidence in combination with clinical expertise and patient values to guide clinical decision‐making. Whilst evidence‐based medicine (EBM) is widely adopted in medicine, EBD is much less frequently used in dentistry. Research into dental students' views towards
Danica Vidović Juras +21 more
wiley +1 more source
Rocuronium-sugammadex as an alternative muscle relaxant to succinylcholine in electroconvulsive therapy: A meta-analysis. [PDF]
Anand R +9 more
europepmc +1 more source
ECT seizure classification [PDF]
W, Buckingham +2 more
openaire +2 more sources
Directrices para la gestión de la Ciberseguridad utilizando el estándar ISO/ECT 27032
Humberto Parra Cárdenas +2 more
openalex +2 more sources
Abstract Objective Despite decades of development in anti‐seizure medications, ~30% of individuals remain refractory to all treatments, and none of the existing therapies are disease modifying. Identifying targets outside the current preclinical paradigm is critically important.
Giovanna L. Durante +4 more
wiley +1 more source

